Defective ZDHHC21 function protects renal function and structure during sepsis injury by attenuating the reduction of renal blood flow, renal perfusion, and renal oxygen saturation
So far the evidence as to whether GLP-1 drugs could benefit Parkinsons disease remains inconclusive (UCL)
doi:10.1080/03007995.2018.1519503 Gelfand AA, Ross AC, Irwin SL, Greene KA, Qubty WF, Allen IE
A single mechanismeven HGF signallingmay be insufficient to address the complex cascade of tau pathology, inflammation, mitochondrial dysfunction, and vascular changes occurring in human disease
GLP-1 receptor agonists work by mimicking the action of the naturally occurring incretin hormone GLP-1, which is released from the intestine in response to food intake